These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
169 related items for PubMed ID: 6289858
1. Enalapril maleate and a lysine analogue (MK-521): disposition in man. Ulm EH, Hichens M, Gomez HJ, Till AE, Hand E, Vassil TC, Biollaz J, Brunner HR, Schelling JL. Br J Clin Pharmacol; 1982 Sep; 14(3):357-62. PubMed ID: 6289858 [Abstract] [Full Text] [Related]
2. Enalapril maleate (MK-421), a potent, nonsulfhydryl angiotensin-converting enzyme inhibitor: absorption, disposition, and metabolism in man. Ulm EH. Drug Metab Rev; 1983 Sep; 14(1):99-110. PubMed ID: 6301792 [Abstract] [Full Text] [Related]
3. Enalapril maleate and a lysine analogue (MK-521) in normal volunteers; relationship between plasma drug levels and the renin angiotensin system. Biollaz J, Schelling JL, Jacot Des Combes B, Brunner DB, Desponds G, Brunner HR, Ulm EH, Hichens M, Gomez HJ. Br J Clin Pharmacol; 1982 Sep; 14(3):363-8. PubMed ID: 6289859 [Abstract] [Full Text] [Related]
4. The physiological disposition and metabolism of enalapril maleate in laboratory animals. Tocco DJ, deLuna FA, Duncan AE, Vassil TC, Ulm EH. Drug Metab Dispos; 1982 Sep; 10(1):15-9. PubMed ID: 6124377 [Abstract] [Full Text] [Related]
5. Pharmacokinetics of repeated single oral doses of enalapril maleate (MK-421) in normal volunteers. Till AE, Gomez HJ, Hichens M, Bolognese JA, McNabb WR, Brooks BA, Noormohamed F, Lant AF. Biopharm Drug Dispos; 1984 Sep; 5(3):273-80. PubMed ID: 6091806 [Abstract] [Full Text] [Related]
6. Effect of a new angiotensin converting enzyme inhibitor MK 421 and its lysine analogue on the components of the renin system in healthy subjects. Brunner DB, Desponds G, Biollaz J, Keller I, Ferber F, Gavras H, Brunner HR, Schelling JL. Br J Clin Pharmacol; 1981 May; 11(5):461-7. PubMed ID: 6268131 [Abstract] [Full Text] [Related]
7. Angiotensin-converting enzyme (ACE) inhibitor transport in human intestinal epithelial (Caco-2) cells. Thwaites DT, Cavet M, Hirst BH, Simmons NL. Br J Pharmacol; 1995 Mar; 114(5):981-6. PubMed ID: 7780654 [Abstract] [Full Text] [Related]
9. Influence of food on the bioavailability of enalapril. Swanson BN, Vlasses PH, Ferguson RK, Bergquist PA, Till AE, Irvin JD, Harris K. J Pharm Sci; 1984 Nov; 73(11):1655-7. PubMed ID: 6097665 [Abstract] [Full Text] [Related]
10. Total serum angiotensin converting enzyme activity in rats and dogs after enalapril maleate (MK-421). Ulm EH, Vassil TC. Life Sci; 1982 Apr 05; 30(14):1225-30. PubMed ID: 6283285 [Abstract] [Full Text] [Related]
11. Enalapril and lisinopril in renovascular hypertension--antihypertensive and hormonal effects of two new angiotensin-converting-enzyme (ACE) inhibitors. A preliminary report. Karlberg BE, Fyhrquist F, Grönhagen-Riska C, Tikkanen I, Ohman KP. Scand J Urol Nephrol Suppl; 1984 Apr 05; 79():103-6. PubMed ID: 6089307 [Abstract] [Full Text] [Related]
12. Tissue angiotensin converting enzyme inhibition as an index of the disposition of enalapril (MK-421) and metabolite MK-422. Cohen ML, Kurz KD, Schenck KW. J Pharmacol Exp Ther; 1983 Jul 05; 226(1):192-6. PubMed ID: 6306224 [No Abstract] [Full Text] [Related]
13. Pharmacokinetics of enalapril and lisinopril in subjects with normal and impaired hepatic function. Hayes PC, Plevris JN, Bouchier IA. J Hum Hypertens; 1989 Jun 05; 3 Suppl 1():153-8. PubMed ID: 2550638 [Abstract] [Full Text] [Related]
14. Effect of dietary sodium on angiotensin-converting enzyme (ACE) inhibition and the acute hypotensive effect of enalapril (MK-421) in essential hypertension. Jackson B, Cubela R, Johnston CI. J Hypertens; 1984 Aug 05; 2(4):371-7. PubMed ID: 6099390 [Abstract] [Full Text] [Related]
15. Comparative pharmacokinetics of enalapril and lisinopril, alone and with hydralazine. McLean AJ, Drummer OH, Smith HJ, Froomes P, McNeil JJ. J Hum Hypertens; 1989 Jun 05; 3 Suppl 1():147-51. PubMed ID: 2550637 [Abstract] [Full Text] [Related]
16. Successful treatment of the crisis of scleroderma with enalapril maleate (MK-421). Ogawa K, Kurose T, Kuwahara T, Ishikawa K, Matsunaga M, Nakamura Y, Pak CH, Hara A, Kawai C. Tohoku J Exp Med; 1984 Dec 05; 144(4):433-4. PubMed ID: 6098974 [Abstract] [Full Text] [Related]
17. Acute and chronic effects of the converting enzyme inhibitors enalapril and lisinopril on reflex control of heart rate in normotensive man. Ajayi AA, Campbell BC, Howie CA, Reid JL. J Hypertens; 1985 Feb 05; 3(1):47-53. PubMed ID: 2987341 [Abstract] [Full Text] [Related]
18. Serum concentration and effects of a single dose of enalapril maleate in patients with essential hypertension. Shionoiri H, Gotoh E, Miyazaki N, Yasuda G, Takagi N, Uneda S, Kaneko Y. Jpn Circ J; 1985 Jan 05; 49(1):46-51. PubMed ID: 2982051 [Abstract] [Full Text] [Related]
19. Angiotensin converting enzyme activity in human serum: relationship to enzyme inhibitor in vivo and in vitro. Swanson BN, Hichens M, Mojaverian P, Ferguson RK, Vlasses PH, Dudash M. Res Commun Chem Pathol Pharmacol; 1981 Sep 05; 33(3):525-36. PubMed ID: 6276950 [Abstract] [Full Text] [Related]
20. Effect of N-[(S)-1-carboxy-3-phenylpropyl]-L-Ala-L-Pro and its ethyl ester (MK-421) on angiotensin converting enzyme in vitro and angiotensin I pressor responses in vivo. Gross DM, Sweet CS, Ulm EH, Backlund EP, Morris AA, Weitz D, Bohn DL, Wenger HC, Vassil TC, Stone CA. J Pharmacol Exp Ther; 1981 Mar 05; 216(3):552-7. PubMed ID: 6259322 [Abstract] [Full Text] [Related] Page: [Next] [New Search]